Connect with us

Hi, what are you looking for?

Economy

Gov’t approves emergency use of AstraZeneca COVID vaccine

THE LOCAL Food and Drug Administration (FDA) has approved the emergency use of AstraZeneca Plc’s coronavirus vaccine in the Philippines, the second approval after Pfizer, Inc.

Evidence and data show it is reasonable to believe that the vaccine might be effective against the coronavirus disease 2019 (COVID-19) virus, FDA Director General Rolando Enrique D. Domingo told an online news briefing on Thursday. The benefits outweigh potential risks, he added.

The vaccine had no safety concerns and its adverse effects were “transient and mostly mild to moderate, similar to common vaccine reactions,” he said.

AstraZeneca’s vaccine has an efficacy of 70% after the first dose and requires a second dose after four to 12 weeks, Mr. Domingo said.

In a statement, the British drug maker said the vaccine could be given to people 18 years old and above. 

It can be stored and handled at normal refrigerated conditions at 2 to 8 degrees Celsius for at least six months.

“This emergency use authorization (EUA) will give millions of Filipinos access to AstraZeneca’s effective, well-tolerated and simple-to-administer vaccine once supply becomes available,” AstraZeneca Philippines Country President Lotis Ramin said in the statement.

“We will continue to fulfill our commitment to provide broad and equitable access at no profit as we work with the Philippine government to pave the way for a return to normalcy and the country’s full economic recovery,” she added.

The National government, local government units (LGUs) and private sector signed an agreement to buy 17 million doses of Astrazeneca vaccines this month.

Russia’s Gamaleya Research Institute of Epidemiology and Microbiology, China’s Sinovac Biotech Ltd. and India’s Bharat Biotech also have pending applications for emergency use in the Philippines. — Vann Marlo M. Villegas

Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Get the daily email that makes reading the news actually enjoyable. Stay informed and entertained, for free.
Your information is secure and your privacy is protected. By opting in you agree to receive emails from us. Remember that you can opt-out any time, we hate spam too!

Latest

Economy

Pag-IBIG Fund has financed 5,411 socialized homes for minimum-wage and low-income members in the first four months of 2022, its top executives said today....

Economy

SRI LANKA’s impending default on $12.6 billion of overseas bonds is flashing a warning sign to investors in other developing nations that surging inflation...

Economy

A WOMAN observes a period calendar tracker app on her mobile phone at her home in Madrid, Spain, May 16. — REUTERS MADRID —...

Economy

WASHINGTON — The US Justice Department on Tuesday sued Steve Wynn, the former CEO of Wynn Resorts, to compel him to register as an...

Economy

WASHINGTON/SEOUL — Despite battling a wave of suspected coronavirus disease 2019 (COVID-19) infections, North Korea appears to be preparing to test an intercontinental ballistic...

Economy

IN MANY PARTS of the world, inflation is climbing quickly, including in the US, where I live and where inflation is now north of...

You May Also Like

Investing

Having a good Instagram marketing agency to back up your Instagram account is an absolute must going into the new year. With competition stronger...

Economy

Ivermectin, an existing drug against parasites including head lice, has had a checkered history when it comes to treating COVID-19. The bulk of studies...

Investing

Insomnia is the most common sleep disorder in the global population. Therefore, it is a problem that many people suffer or have suffered throughout...

Investing

As a traditionally rigid insurance industry becomes bogged down by antiquated processes and operations, a handful of industry leaders are seeking to shake things...

Disclaimer: SmartRetirementReport.com, its managers, its employees, and assigns (collectively "The Company") do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

Copyright © 2021 SmartRetirementReport. All Rights Reserved.